{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:18:32Z","timestamp":1788254312391,"version":"build-2803163510"},"reference-count":15,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,4,15]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1183\/23120541.00131-2026","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:10:49Z","timestamp":1787793049000},"page":"00131-2026","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4904-1405","authenticated-orcid":false,"given":"Ebrahim","family":"AlEissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-4513","authenticated-orcid":false,"given":"Lisa","family":"Kolkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Kapasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steeve","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Swiston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"2026090101501060000_12.5.00131-2026.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.911818"},{"key":"2026090101501060000_12.5.00131-2026.2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40256-017-0262-z","article-title":"Targeting the prostacyclin pathway with selexipag in patients with pulmonary arterial hypertension receiving double combination therapy: insights from the randomized controlled GRIPHON study","volume":"18","author":"Coghlan","year":"2018","journal-title":"Am J Cardiovasc Drugs"},{"key":"2026090101501060000_12.5.00131-2026.3","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur Respir J"},{"key":"2026090101501060000_12.5.00131-2026.4","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01325-2024"},{"key":"2026090101501060000_12.5.00131-2026.5","doi-asserted-by":"crossref","first-page":"2102311","DOI":"10.1183\/13993003.02311-2021","article-title":"COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension","volume":"60","author":"Hoeper","year":"2021","journal-title":"Eur Respir J"},{"key":"2026090101501060000_12.5.00131-2026.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02418-2019"},{"key":"2026090101501060000_12.5.00131-2026.7","doi-asserted-by":"crossref","first-page":"2045894019862167","DOI":"10.1177\/2045894019862167","article-title":"Transition from parental prostacyclin to selexipag: a case series of five pulmonary arterial hypertension patients","volume":"9","author":"Holthaus","year":"2019","journal-title":"Pulm Circ"},{"key":"2026090101501060000_12.5.00131-2026.8","first-page":"42","article-title":"Safe and successful transition from oral selexipag to subcutaneous treprostinil in a patient with idiopathic pulmonary arterial hypertension treated with triple combination therapy","volume":"26","author":"Adachi","year":"2022","journal-title":"J Cardiol Cases"},{"key":"2026090101501060000_12.5.00131-2026.9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5505\/respircase.2022.55476","article-title":"Transition from oral selexipag to subcutaneous treprostinil in a patient with idiopathic pulmonary arterial hypertension: an eight-day protocol","volume":"11","author":"Ho","year":"2022","journal-title":"Respir Case Rep"},{"key":"2026090101501060000_12.5.00131-2026.10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.chest.2018.03.050","article-title":"Mortality in patients with pulmonary arterial hypertension treated with continuous prostanoids","volume":"154","author":"Bartolome","year":"2018","journal-title":"Chest"},{"key":"2026090101501060000_12.5.00131-2026.11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.healun.2019.05.002","article-title":"Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension","volume":"38","author":"Olsson","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2026090101501060000_12.5.00131-2026.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503184"},{"key":"2026090101501060000_12.5.00131-2026.13","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jacc.2021.07.057","article-title":"Three- versus two-drug therapy for patients with newly diagnosed pulmonary arterial hypertension","volume":"78","author":"Chin","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026090101501060000_12.5.00131-2026.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202009-3698OC"},{"key":"2026090101501060000_12.5.00131-2026.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2415160"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00131-2026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:50:19Z","timestamp":1788252619000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00131-2026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9,1]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1183\/23120541.00131-2026"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00131-2026","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}